ARRY
Price
$6.91
Change
+$0.23 (+3.44%)
Updated
Jul 25 closing price
Capitalization
2.22B
12 days until earnings call
TBPH
Price
$11.06
Change
-$0.07 (-0.63%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
551.51M
16 days until earnings call
Interact to see
Advertisement

ARRY vs TBPH

Header iconARRY vs TBPH Comparison
Open Charts ARRY vs TBPHBanner chart's image
Array Technologies
Price$6.91
Change+$0.23 (+3.44%)
Volume$4.47M
Capitalization2.22B
Theravance Biopharma
Price$11.06
Change-$0.07 (-0.63%)
Volume$5.34K
Capitalization551.51M
ARRY vs TBPH Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. TBPH commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Hold and TBPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (TBPH: $11.03)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TBPH’s FA Score shows that 0 FA rating(s) are green while.

  • TBPH’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while TBPH’s TA Score has 3 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 5 bearish.
  • TBPH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than TBPH.

Price Growth

TBPH (@Biotechnology) experienced а -1.96% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

TBPH is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than TBPH($552M). TBPH YTD gains are higher at: 17.216 vs. ARRY (14.404). ARRY has higher annual earnings (EBITDA): 276M vs. TBPH (-42.3M). ARRY has more cash in the bank: 249M vs. TBPH (131M). TBPH has less debt than ARRY: TBPH (48.2M) vs ARRY (730M). ARRY has higher revenues than TBPH: ARRY (1.58B) vs TBPH (65.3M).
ARRYTBPHARRY / TBPH
Capitalization2.22B552M403%
EBITDA276M-42.3M-652%
Gain YTD14.40417.21684%
P/E Ratio26.23N/A-
Revenue1.58B65.3M2,415%
Total Cash249M131M190%
Total Debt730M48.2M1,515%
FUNDAMENTALS RATINGS
ARRY vs TBPH: Fundamental Ratings
ARRY
TBPH
OUTLOOK RATING
1..100
5817
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
5348
P/E GROWTH RATING
1..100
31100
SEASONALITY SCORE
1..100
70n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TBPH's Valuation (37) in the Pharmaceuticals Other industry is somewhat better than the same rating for ARRY (89) in the Biotechnology industry. This means that TBPH’s stock grew somewhat faster than ARRY’s over the last 12 months.

TBPH's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ARRY (100) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ARRY’s over the last 12 months.

TBPH's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as ARRY (100) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ARRY’s over the last 12 months.

TBPH's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as ARRY (53) in the Biotechnology industry. This means that TBPH’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (31) in the Biotechnology industry is significantly better than the same rating for TBPH (100) in the Pharmaceuticals Other industry. This means that ARRY’s stock grew significantly faster than TBPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYTBPH
RSI
ODDS (%)
Bullish Trend 26 days ago
83%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WHIYX5.96N/A
N/A
Macquarie High Income Fund Class Y
TLGCX9.47N/A
N/A
Timothy Plan Large/Mid Cap Growth C
OBCHX8.94N/A
N/A
Oberweis China Opportunities
AKRSX76.61N/A
N/A
Akre Focus Supra Institutional
TCSHX15.30N/A
N/A
Transamerica Multi-Asset Income C

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-0.90%
KYMR - TBPH
40%
Loosely correlated
-0.13%
BPMC - TBPH
38%
Loosely correlated
N/A
ELEV - TBPH
38%
Loosely correlated
N/A
AXON - TBPH
34%
Loosely correlated
+3.63%
ARRY - TBPH
34%
Loosely correlated
+3.44%
More